Tabuteau Herriot's Form 4 filing
Axsome Therapeutics, Inc. (AXSM) · filed Aug 7, 2026
- Accession no.
- 0001193125-26-340688
- Filed
- Aug 7, 2026, 7:00 PM ET
- Trade date
- Aug 5-6, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $10.5M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tabuteau HerriotCIK 0001219927 | Director, Officer (Chief Executive Officer), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | Common Stock | MOption exerciseAcquired | +45,004 | $4.95 | +$222,769.8 | 52,233 | Direct | |
| Aug 5, 2026 | Common Stock | SSaleDisposed | −45,004 | $212.01F4 | −$9,541,298.04 | 7,229 | Direct | |
| Aug 6, 2026 | Common Stock | MOption exerciseAcquired | +4,660 | $4.95 | +$23,067 | 11,889 | Direct | |
| Aug 6, 2026 | Common Stock | SSaleDisposed | −4,660 | $213.95F5 | −$997,007 | 7,229 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | Common Stock | MOption exerciseDisposed | −45,004 | $0.00 | $0 | 4,660 | Direct | |
| Aug 6, 2026 | Common Stock | MOption exerciseDisposed | −4,660 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F4
Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $209.28 and $216.35.
Referenced by the price of 1 transaction in Table I.
- F5
Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $212.41 and $216.36.
Referenced by the price of 1 transaction in Table I.